FORWARD FEATURES CALENDAR

Funds

Investcorp acquires Vivaticket

Investcorp, a provider and manager of alternative investment products, is to acquire Ticket Holding (Vivaticket) from co-founders Luca Montebugnoli and Luana Sabattini, P4P of Giuseppe Camillo Pilenga, Girefin Trust of Stefano Landi and Bravo Capital Partners SCA RAIF (BCP).  Vivaticket’s co-founders and management team will continue to remain involved in

ACTIAM employs satellite data to combat deforestation

Asset manager ACTIAM has teamed with geodata analytics firm Satelligence to combine satellite images and Artificial Intelligence (AI), to provide up-to-date information on worldwide deforestation, causes and trends. The cooperation enables ACTIAM to incorporate advanced sustainability information into its investment policies and portfolio management, helping to fight global deforestation.  

C5 Capital leads USD51 million growth funding round in Shape Security

Shape Security, an online fraud prevention platform, has secured USD51 million in a funding round led by C5 Capital, a specialist venture capital firm focused on cyber security, data analytics and cloud computing. Investing alongside C5 are Silicon Valley and corporate investors Kleiner Perkins, HPE Growth, Norwest Ventures Partners, Focus

US buyout fundraising activity reaching its highest quarterly volume

CEPRES has released its latest Private Capital Market Outlook report showing that US buyout fundraising activity increased in Q2-2019 by more than 10% reaching its highest quarterly volume. The fundraising activity coincides with the overall increase in US buyout entry EBITDA pricing multiples that have breached 11x in the median case

RSK Group acquires Ecologia

RSK, a UK environmental, engineering and technical services consultancy, has acquired Ecologia Environmental Solutions Ltd. The multidisciplinary site remediation specialist is the sixth acquisition for the rapidly expanding RSK group this financial year. With headquarters in Sittingbourne, Kent, further UK offices in Stafford and Devon, and an office in Bologna,

Appetite still strong for casual dining investments despite high street challenges

Investor appetite remains strong for specific opportunities with the right dynamics in the UK’s casual dining sector – despite the current challenging conditions on the high street, according to Connection Capital, a specialist private client investment business. The firm recently completed an allocation to a management buyout (MBO) of Rosa’s

HKW portfolio company Fresh Direct Produce acquires Islands West

Fresh Direct Produce, a portfolio company of middle market private equity firm HKW, has acquired Islands West Manufacturing (Islands West). Financial terms of the transaction have not been disclosed.   Founded in 1995 and headquartered in Victoria, British Columbia, Islands West is a family-owned wholesaler of produce, processed fruits, dried spices,

PE-backed Lucid Group acquires Healthcare 21

Lucid Group, a portfolio company of private equity investor LDC and a specialist in healthcare communications, has acquired healthcare consultancy Healthcare 21. Lucid Group currently comprises five medical communications specialists, Bluedog, Leading Edge, Lighthouse, Lucid Partners and ViVid. HealthCare21 meanwhile, has been producing healthcare materials and programmes for its clients,

KKR makes major investment in Burning Glass

KKR has acquired a majority stake in Burning Glass Technologies, a real-time labour market data source, from Providence Strategic Growth. Financial details of the transaction have not been disclosed. The investment is part of KKR’s Global Impact strategy, which is focused on identifying and investing behind companies whose core business

Pappas Capital, an investor in early-stage life sciences companies, has appointed Alex Arfaei as a Partner of Pappas Ventures.

Arfaei will be responsible for helping to identify and evaluate investment opportunities for the firm’s venture capital business. Previously, he  served as a Managing Director with BMO Capital Markets, where he was a senior equity research analyst covering major pharmaceutical and biotechnology companies. “Alex’s unique combination of equity research and

Events

12 November, 2026 – 5:00 pm

Directory Listings